Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Freeman-Sheldon Syndrome Quality of Life Study (FSS-QLS): Cross-sectional Study of Concomitant Disorder-Specific Contributors to Quality of Life and Clinical Outcome

NCT01307475 is registered in ClinicalTrials.gov with Freeman-Sheldon Research Group, Inc. as lead sponsor.

NCT NCT01307475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01307475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Freeman-Sheldon Syndrome Quality of Life Study (FSS-QLS): Cross-sectional Study of Concomitant Disorder-Specific Contributors to Quality of Life and Clinical Outcome
Lead sponsor
Freeman-Sheldon Research Group, Inc.
Phase
Observational
Overall status
Terminated
Start date
February 28, 2011
Completion date
April 1, 2017
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthrogryposis, craniofacial abnormalities, depressive disorder, posttraumatic stress disorder